Drug: rituximab Quarter: 2016Q3
Total Records: 1,104 Number of Pages: 56
DRUGNAME | PT | EventCount |
---|---|---|
Rituximab | Primary myelofibrosis | 3 |
RITUXIMAB | Pulmonary toxicity | 3 |
rituximab | Respiratory disorder | 3 |
RITUXIMAB | Retching | 3 |
RITUXIMAB | Splenomegaly | 3 |
Rituximab | Stress fracture | 3 |
RITUXIMAB | Strongyloidiasis | 3 |
Rituximab | Synovial cyst | 3 |
RITUXIMAB | Synovitis | 3 |
Rituximab | Temporal arteritis | 3 |
Rituximab | Thyroid cyst | 3 |
Rituximab | Tibia fracture | 3 |
Rituximab | Transaminases increased | 3 |
Rituximab | Tremor | 3 |
Rituximab | Uterine polyp | 3 |
RITUXIMAB | Vasculitis | 3 |
RITUXIMAB | Viral infection | 3 |
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Haemoglobin decreased | 3 |
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Pain | 3 |
RITUXIMAB (MOAB C2B8 ANTI CD20, CHIMERIC) | Pancytopenia | 3 |
Total Records: 1,104 Number of Pages: 56